Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02859246 · ClinicalTrials.gov registry record · NA
Mucinex® for Treatment of Filamentary Keratitis
A NA study, sponsored by Massachusetts Eye and Ear Infirmary.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT02859246 is a NA study that has completed, run by Massachusetts Eye and Ear Infirmary. The registered enrollment target is 15 participants.
The verdict
NCT02859246, a NA study, has completed, sponsored by Massachusetts Eye and Ear Infirmary.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
It is a pilot study aimed to determine if oral Mucinex® is effective in reducing the amount of corneal filaments and improving symptomology in subjects with filamentary keratitis.
Interventions
- DRUG Mucinex®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2016-09 |
| Est. Completion | 2018-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02859246
The ClinicalTrials.gov registry entry for NCT02859246 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts Eye and Ear Infirmary, which has 73 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Mucinex® is the first listed.
NCT02859246 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02859246 about?
NCT02859246 is a clinical study titled "Mucinex® for Treatment of Filamentary Keratitis". It is a pilot study aimed to determine if oral Mucinex® is effective in reducing the amount of corneal filaments and improving symptomology in subjects with filamentary keratitis.
What is the current status of trial NCT02859246?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2016-09. Estimated completion is 2018-07.
What interventions are being tested in trial NCT02859246?
The interventions under investigation include: Mucinex® (DRUG).
Who is sponsoring clinical trial NCT02859246?
This trial is sponsored by Massachusetts Eye and Ear Infirmary, which has 73 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.